Home
About
Overview
Sharing Data
ORCID
Help
History (11)
Tyrothricin
Depression in Parents Who Live in Rural Communities: What Do We Know?
Minimal Clinically Important Difference and Substantial Clinical Benefit Values for the 12-Item International Hip Outcome Tool.
Coronary Vessels
Development of mavoglurant and its potential for the treatment of fragile X syndrome.
See All 11 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Development of mavoglurant and its potential for the treatment of fragile X syndrome.
Development of mavoglurant and its potential for the treatment of fragile X syndrome. Expert Opin Investig Drugs. 2014 Jan; 23(1):125-34.
View in:
PubMed
subject areas
Animals
Fragile X Syndrome
Humans
Indoles
Receptor, Metabotropic Glutamate 5
authors with profiles
Elizabeth Berry-Kravis